Exam 4: Viral Hepatitis Flashcards

1
Q

What is hepatitis?

A

Inflammation of the liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the 3 most common viruses that cause viral hepatitis? (note there are 5 total)

A

Hepatitis A virus
Hepatitis B virus
Hepatitis C virus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What type of virus is hepatitis?

A

RNA

*except HBV is DNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which forms of hepatitis can cause a chronic infection?

A

HBV
HCV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the main route of transmission for HAV?

A

Fecal-Oral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the main routes of transmission for HBV?

A

Blood
Sexual

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the main route of transmission for HCV?

A

Blood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the most common risk factor for getting HAV?

A

Direct contact with someone with HAV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the most common risk factor for getting HBV?

A

Born to infected mother

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the most common risk factor for getting HCV?

A

Injection drug use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

The vaccine against which form of hepatitis is recommended at birth?

A

HBV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Which form of hepatitis does not require chronic treatment?

A

HAV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Chronic treatment of which hepatitis form is CURATIVE?

A

HCV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Chronic treatment of which hepatitis form is NOT CURATIVE?

A

HBV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the only form of hepatitis without a vaccine available?

A

HCV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the 2 methods for diagnosing HAV?

A

Presence of IgM anti-HAV in the serum

Presence oh HAV RNA in the serum/stool

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Which antibody is responsible for providing lifelong immunity to HAV?

A

IgG anti-HAV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

How do we assess immunity to HAV?

A

Total anti-HAV present

(Measure both IgG and IgM)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

How do we treat HAV infection?

A

We don’t!

-Supportive care

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

When should the HAV vaccine typically be given?

A

2 dose series:
0 months and 6-12 months

Post-exposure prophylactic vaccine should be given ASAP after exposure
-in people >12 months old
*Give IM immune globulin if < 12 mo old
*Give both immune globulin and vaccine if >40 years old with increased risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

True or False: The HAV vaccine is safe in pregnancy

A

True

(it is an inactivated vaccine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What side effect is unique to HAV?

A

diarrhea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Who should be screened for HBV?

A

Adults age 18 and older at least once in their lifetime using a triple panel test

Screen for HBsAg during each pregnancy

Test people at ongoing risk periodically

Test anyone who requests to be tested

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What 3 markers are tested in an HBV triple panel test?

A

Hepatitis B Surface Antigen (HBsAg)

Antibody to hepatitis B surface antigen (anti-HBs)

Antibody to hepatitis B core antigen (Total anti-HBc)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Which marker of HBV tells us if the patient is infectious or not?

A

Hepatitis B Surface Antigen (HBsAg)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Which marker of HBV tells us if the patient is immune or not?

A

Antibody to hepatitis B surface antigen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Which marker of HBV tells us if the patient has been exposed to the HBV virus?

A

Antibody to hepatitis B core antigen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

If all 3 HBV markers in a triple panel come back negative, and the patient is susceptible but never infected, what do we do?

A

Offer HepB vaccine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

If in an HBV triple panel, HBsAg is negative, anti-HBs is positive, and anti-HBc is positive, what does this mean and what do we do?

A

Resolved infection

Counsel about HBV reactivation risk

30
Q

If in an HBV triple panel, HBsAg is negative, anti-HBs is positive, and anti-HBc is negative, what does this mean and what do we do?

A

Patient has immunity from a prior vaccination
(if documented)

If not vaccinates, complete the vaccine series

31
Q

If in an HBV triple panel, HBsAg is positive, anti-HBs is negative, anti-HBc is positive, and IGM anti-HBc is positive, what does this mean and what do we do?

A

Acute infection

Link to hepatitis B care

32
Q

If in an HBV triple panel, HBsAg is positive, anti-HBs is negative, anti-HBc is positive, and IgM anti-HBc is negative, what does this mean and what do we do?

A

Chronic infection

Link to hepatitis B care

33
Q

How do we treat an acute HBV infection?

A

No treatment

Supportive care

34
Q

When do we use medication therapy to treat HBV?

A

Chronic infection

35
Q

What 3 tests do we do on a patient with chronic HBV to figure out what phase they are in?

A

Liver panel

HBeAg

HBV DNA PCR

36
Q

What is the clinical threshold that HBV DNA must be above in order to treat for HBV?

A

> /= 2000 IU/mL
(>/= 10,000 copies/mL)

37
Q

ALT is normally elevated in HBV infection, what is the upper limit of normal for men and women?

A

Men: 35 U/L

Women: 25 U/L

38
Q

Do we use monotherapy or combination therapy for HBV treatment?

A

Monotherapy

*combination therapy has not shown higher efficacy

39
Q

How long does nucleoside analog therapy typically last for HBV?

A

Indefinite

40
Q

What requirements must be met with HBV infection to me eligible for treatment?

A

HBV DNA > 2000 IU/mL
+
ALT > 2xULN or Cirrhosis

41
Q

If a patient has the e+ Immune-active phase of chronic HBV, what criteria must they meet to be given treatment?

A

ALT > 2xULN
HBV DNA > 20,000 IU/mL ***

42
Q

What are the first-line nucleoside analogs used for HBV treatment?

A

Tenofovir (TDF) 300 mg po daily

Tenofovir alafenamide 25 mg po daily
this tends to be reserved 2nd line

Entecavir
-use 0.5 mg po daily in nucleoside naive patients
-use 1 mg po daily in nucleoside-experienced patients

43
Q

What are the other agents that can be used for HBV besides the 1st line treatment?

A

Nucleoside analogs:
-Lamivudine
-Adefovir
-Telbivudine

Cytokine
-not in US

44
Q

What side effects are we worried about with Tenofovir Disoproxil Fumarate?

A

*Nephropathy

Fanconi syndrome

Osteomalacia

Lactic acidosis

45
Q

What side effect are we worried about with all 3 of the first-line nucleoside analogs for HBV? (entecavir, tenofovir disoproxil fumarate, tenofovir alafenamide)

A

Lactic acidosis

46
Q

Who has a higher risk for HBV reactivation/flares?

A

Patients who test positive for both anti-HBc and HBsAg

47
Q

What is the treatment for HBV in pregnant women?

A

Beginning at week 28-32 of gestation, treat pregnant women who have HBV DNA > 200,000 IU/mL with tenofovir DF

*note: only use tenofovir DF, no other forms/drugs

48
Q

What treatment is frequently used for HBV/ HIV coinfection?

A

Emtricitabine + Tenofovir

49
Q

When is the HBV vaccine typically administered and how many doses?

A

3 doses at: 0, 1, and 6 months old

50
Q

Hepatitis C is divided into what categories?

A

7 major genotypes (1-7)

then, further classified into 67 subtypes (a, b, c, etc)

51
Q

What are the most common types of HCV in the us?

52
Q

What are the 2nd most common genotypes of HCV?

53
Q

How is HCV spread?

A

Repeated percutaneous exposures to infected blood

54
Q

What is considered a chronic HCV infection?

A

Persistently detectable HCV RNA for >/= 6 months

55
Q

How do we diagnose HCV infection?

A

Presence of HCV RNA

56
Q

Who should be screened for HCV?

A

All US adults

Pregnant women during every pregnancy

57
Q

What is the goal of HCV therapy?

A

Obtain a virological cure by achieving sustained virological response (SVR)

SVR= HCV RNA is undetectable 12 weeks after cessation of treatment

58
Q

Who should receive treatment for HCV?

A

All people with chronic HCV

-except those with short life expectancies (<12 mo)

59
Q

Should we use combination therapy in HCV treatment?

A

Yes, it prevents resistance

60
Q

All Direct Acting Antivirals (DAAs) used in HCV treatment have what black box warning?

A

Risk of Hepatitis B reactivation

61
Q

What are the NS3/4A Protease Inhibitors that can be used in HCV treatment?

A

*Grazoprevir 100 mg po daily or with/without food
Glecaprevir
Voxilaprevir

62
Q

What is an important clinical pearl about Grazoprevir therapy?

A

Patients should have ALT checked at 8 weeks, discontinue if >5xULN

63
Q

What are the NS5B Polymerase Inhibitors used for HCV treatment?

A

“buvir” = NS5B

Sofosbuvir (no hepatic dose adjustment)

*this is the only one left

64
Q

What are the NS5A replication complex inhibitors used for HCV treatment?

A

“asvir”= NS5A

Ledipasvir
Elbasvir
Velpatasvir
Pibrentasvir

65
Q

What is an important clinical pearl regarding Elbasvir use in HCV?

A

Prior to use in patients with an HCV genotype 1a, an NS5A genotype must be performed to screen for the presence of resistance-associated substitutions (RASs) at baseline

Presence of any substitutions at codons: 28, 30, 31, or 93 requires extended 16 week course + ribavirin

66
Q

What is an important clinical pearl for Velpatasvir use in HCV treatment?

A

Prior to use, in compensated cirrhotic patients with HCV genotype 3, an NS5A genotype must be performed to screen for the presence of the Y93H substitution
-presence requires adding ribavirin or voxilaprevir

67
Q

What are the FDA Approved combinations for HCV treatment?

A

Elbasvir + Grasoprevir
Pibrntasvir + Glecaprevir
Velpatasvir + Sofosbuvir + Voxilaprevir 2nd line
Ledipasvir + Sofosbuvir
Velpatasvir + Sofosbuvir

68
Q

Which combination product is 3 tablets daily taken with food?

A

Pibrentasvir + Glecaprevir

69
Q

What are the most common side effects of ribavirin?

A

*Hemolytic anemia
*Teratogenic

70
Q

Who is ribavirin contraindicated in?

71
Q

How long does HCV therapy last?

72
Q

Which regimen is a predominantly 8 week course?

A

Pibrentasvir + Glecaprevir